Cost-effectiveness of an outreach program for HCC screening in patients with cirrhosis: a microsimulation modeling study

被引:0
|
作者
Gurley, Tami [1 ]
Hernaez, Ruben [2 ,3 ]
Cerda, Vanessa [1 ]
Thomas, Tynaje [1 ]
Narasimman, Manasa [4 ]
Mittal, Sukul [4 ]
Al-Hasan, Mohammed [4 ]
Daher, Darine [4 ]
Singal, Amit G. [4 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Donnell Sch Publ Hlth, Dallas, TX USA
[2] Michael E DeBakey VA Med Ctr, Dept Med, Houston, TX USA
[3] Baylor Coll Med, Houston, TX USA
[4] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX USA
关键词
Liver cancer; Screening; Ultrasound; Outreach; Interventions; HEPATOCELLULAR-CARCINOMA SURVEILLANCE; DECOMPENSATED CIRRHOSIS; ASSOCIATION; OUTCOMES; QUALITY; DISEASE; LIFE;
D O I
10.1016/j.eclinm.2025.103113
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Patients with cirrhosis are at high risk for hepatocellular carcinoma (HCC), but few undergo guideline- recommended semi-annual screening. Randomized clinical trials (RCTs) demonstrate that mailed outreach can increase screening versus visit-based screening. We estimated the costs and cost-effectiveness of an outreach strategy versus usual care. Methods We built a 10-year Markov chain Monte Carlo microsimulation model to conduct a cost-effectiveness analysis comparing a mailed outreach program versus usual care for HCC screening in a cohort of 10,000 patients with cirrhosis. Model inputs were based on literature review (2005-current), and costs were based on inflation-adjusted estimates from Surveillance, Epidemiology, and End Results (SEER)-Medicare claims data. We conducted one-way sensitivity analyses for HCC incidence, outreach costs, efficacy of the outreach strategy to increase screening, and efficacy of curative (versus palliative) HCC treatments. Findings Mailed outreach was estimated to cost $32.45 per patient in the first year and $21.90 per patient in subsequent years. The outreach program increased the number of HCC patients detected at an early stage by 48.4% and increased quality-adjusted life years (QALYs) by 300. Cost savings from these increases offset the costs of mailed outreach. Mailed outreach remained cost-effective across a wide range of HCC incidence rates, outreach costs, efficacy of the outreach strategy to increase screening, and the efficacy of curative HCC treatments. Annual out-ofpocket patient costs in the outreach arm were low at $13 per year. Interpretation Mailed outreach to encourage HCC screening in patients with cirrhosis dominates usual care and should be considered for implementation in routine practice. Funding National Cancer Institute and Cancer Prevention Research Institute of Texas. Copyright (c) 2025 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Cost-Effectiveness of Public Health Measures to Control COVID-19 in China: A Microsimulation Modeling Study
    Wang, Qiang
    Shi, Naiyang
    Huang, Jinxin
    Yang, Liuqing
    Cui, Tingting
    Ai, Jing
    Ji, Hong
    Xu, Ke
    Ahmad, Tauseef
    Bao, Changjun
    Jin, Hui
    FRONTIERS IN PUBLIC HEALTH, 2022, 9
  • [22] Nutritional Policy Changes in the Supplemental Nutrition Assistance Program: A Microsimulation and Cost-Effectiveness Analysis
    Basu, Sanjay
    Seligman, Hilary
    Bhattacharya, Jay
    MEDICAL DECISION MAKING, 2013, 33 (07) : 937 - 948
  • [23] Modeling the Cost-effectiveness of Esophageal Cancer Screening in China
    Li, Yuanyuan
    Du, Lingbin
    Wang, Youqing
    Gu, Yuxuan
    Zhen, Xuemei
    Hu, Xiaoqian
    Sun, Xueshan
    Dong, Hengjin
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2020, 18 (01)
  • [24] Modeling the Cost-effectiveness of Esophageal Cancer Screening in China
    Yuanyuan Li
    Lingbin Du
    Youqing Wang
    Yuxuan Gu
    Xuemei Zhen
    Xiaoqian Hu
    Xueshan Sun
    Hengjin Dong
    Cost Effectiveness and Resource Allocation, 18
  • [25] Modeling Cost-Effectiveness of Cervical Cancer Screening in Hungary
    Voko, Zoltan
    Nagyjanosi, Laszlo
    Margitai, Barnabas
    Koevi, Rita
    Toth, Zoltan
    Laszlo, Daniel
    Kalo, Zoltan
    VALUE IN HEALTH, 2012, 15 (01) : 39 - 45
  • [26] COST-EFFECTIVENESS OF SCREENING
    POLE, JD
    PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1971, 64 (12): : 1256 - &
  • [27] Cost-effectiveness of screening for recurrent hepatocellular carcinoma (HCC) after liver transplant (IT)
    Ladabaum, Uri
    Cheng, Shan L.
    Yao, Francis Y.
    Roberts, John P.
    GASTROENTEROLOGY, 2008, 134 (04) : A762 - A763
  • [28] Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: a cost-effectiveness modeling analysis
    Rajasingham, R.
    Meya, D.
    Greene, G.
    Jordan, A.
    Chiller, T.
    Boulware, D.
    Larson, B.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21 : 33 - 34
  • [29] Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis
    Rajasingham, Radha
    Meya, David B.
    Greene, Gregory S.
    Jordan, Alexander
    Nakawuka, Mina
    Chiller, Tom M.
    Boulware, David R.
    Larson, Bruce A.
    PLOS ONE, 2019, 14 (01):
  • [30] Cost-effectiveness of a cervical screening program with human papillomavirus vaccine
    Sopina, Elizaveta
    Ashton, Toni
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2011, 27 (04) : 290 - 297